Advanced search
Publication Cover
Autoimmunity Volume 49, 2016 - Issue 2
Submit an article Journal homepage
423
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Inhibition of each module of connective tissue growth factor as a potential therapeutic target for rheumatoid arthritis

Tomoko MiyashitaInstitute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan, ;Department of Internal Medicine and Rheumatology, School of Medicine, Juntendo University, Tokyo, Japan,
,
Shinji MorimotoInstitute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan, ;Department of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Chiba, Japan, Correspondence[email protected]
,
Maki FujishiroInstitute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan,
,
Kunihiro HayakawaInstitute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan,
,
Satoshi SuzukiInstitute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan, ;Department of Internal Medicine and Rheumatology, School of Medicine, Juntendo University, Tokyo, Japan,
,
Keigo IkedaInstitute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan, ;Department of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Chiba, Japan,
,
Keiji MiyazawaCentral Research Laboratories, Kissei Pharmaceutical Co Ltd, Nagano, Japan, and
,
Megumi MoriokaNosan Corporation, Kanagawa, Japan
,
Kenji TakamoriInstitute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan,
,
Hideoki OgawaInstitute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan,
,
Iwao SekigawaInstitute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan, ;Department of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Chiba, Japan,
&
Yoshinari TakasakiDepartment of Internal Medicine and Rheumatology, School of Medicine, Juntendo University, Tokyo, Japan,
show all
Pages 109-114 | Received 22 Jul 2015, Accepted 24 Oct 2015, Published online: 19 Nov 2015

References

  • Grotendorst, G. R. 1997. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 8: 171–179
  • Perbal, B. 2004. CCN proteins: multifunctional signalling regulators. Lancet 363: 62–64
  • Takigawa, M., T. Nakanishi, S. Kubota, and T. Nishida. 2003. Role of CTGF/HCS24/ecogenin in skeletal growth control. J. Cell. Physiol. 194: 256–266
  • Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Rheumatoid arthritis. Cell 85: 307–310
  • Itoh, Y., H. Hayashi, K. Miyazawa, et al. 2007. 17β-estradiol induces IL-1α gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor α (ERα) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERα. J. Immunol. 178: 3059–3066
  • Paleolog, E. M. 2009. The vasculature in rheumatoid arthritis: cause or consequence? Int. J. Exp. Pathol. 90: 249–261
  • Nozawa, K., M. Fujishiro, M. Kawasaki, et al. 2009. Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis. Arthritis Res. Ther. 11: R174
  • Nozawa, K., M. Fujishiro, Y. Takasaki, and I. Sekigawa. 2014. Inhibition of rheumatoid arthritis by blocking connective tissue growth factor. World J. Orthop. 5: 653–659
  • Suzuki, S., S. Morimoto, M. Fujishiro, et al. 2014. Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis. Autoimmunity 48: 251–258
  • Chujo, S., F. Shirasaki, M. Kondo-Miyazaki, et al. 2009. Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis. J. Cell. Physiol. 220: 189–195
  • Ikawa, Y., P. S. Ng, K. Endo, et al. 2008. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-β-induced mouse fibrosis. J. Cell. Physiol. 216: 680–687
  • Blaney Davidson, E. N., E. L. Vitters, F. M. Mooren, et al. 2006. Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. Arthritis Rheum. 54: 1653–1661
  • Fernihough, J. K., M. E. Billingham, S. Cwyfan-Hughes, and J. M. Holly. 1996. Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis Rheum. 39: 1556–1565
  • Neidel, J. 2001. Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis. Clin. Exp. Rheumat. 19: 81–84
  • Klimek, E., A. Skalska, B. Kwasny-Krochin, et al. 2014. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. Mediators Inflamm. 2014: 681635
  • Foster, W., G. Y. Lip, K. Raza, et al. 2012. An observational study of endothelial function in early arthritis. Eur. J. Clin. Invest. 42: 510–516
  • Gurol, G., I. H. Ciftci, H. Harman, et al. 2015. Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis. Int. J. Clin. Exp. Pathol. 8: 1979–1984
  • Lawler, J. 1986. The structural and functional properties of thrombospondin. Blood 67: 1197–1209
  • Ohyama, K., A. Kawakami, M. Tamai, et al. 2012. Serum immune complex containing thrombospondin-1: a novel biomarker for early rheumatoid arthritis. Ann. Rheum. Dis. 71: 1916–1917
  • Suzuki, T., N. Iwamoto, S. Yamasaki, et al. 2015. Upregulation of thrombospondin 1 expression in synovial tissues and plasma of rheumatoid arthritis: role of transforming growth factor-β1 toward fibroblast-like synovial cells. J. Rheumatol. 42: 943–947
  • Chen, C. C., and L. F. Lau. 2009. Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem Cell Biol. 41: 771–783
  • Chen, P. S., M. Y. Wang, S. N. Wu, et al. 2007. CTF enhances the motility of breast cancer cells via an integrin- alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. J. Cell Sci. 120: 2053–2065

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.